日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Kindlin-3 phosphorylation is crucial for thrombosis and hemostasis in vivo.

Kindlin-3 磷酸化对于体内血栓形成和止血至关重要

Pluskota Elzbieta, Szpak Dorota, Wang Yunmei, Qin Jun, Simon Daniel I, Plow Edward F, Bialkowska Katarzyna

Platelet and Monocyte Activation After Transcatheter Aortic Valve Replacement (POTENT-TAVR): A Mechanistic Randomized Trial of Ticagrelor Versus Clopidogrel

经导管主动脉瓣置换术后血小板和单核细胞活化(POTENT-TAVR):替格瑞洛与氯吡格雷的机制随机试验

Zidar, David A; Al-Kindi, Sadeer; Longenecker, Chris T; Parikh, Sahil A; Gillombardo, Carl B; Funderburg, Nicholas T; Juchnowski, Steven; Huntington, Lauren; Jenkins, Trevor; Nmai, Christopher; Osnard, Michael; Shishebhor, Mehdi; Filby, Steven; Tatsuoka, Curtis; Lederman, Michael M; Blackstone, Eugene; Attizzani, Guilherme; Simon, Daniel I

Coronary Stenting in High Bleeding Risk Patients With Small Coronary Arteries Followed by One-Month Dual Antiplatelet Therapy: Onyx ONE Clear

冠状动脉支架植入术治疗出血风险高、冠状动脉细小的患者,术后辅以一个月双联抗血小板治疗:Onyx ONE Clear

Moreno, Raúl; Kandzari, David E; Kirtane, Ajay J; Windecker, Stephan; Latib, Azeem; Kedhi, Elvin; Mehran, Roxana; Price, Matthew J; Simon, Daniel I; Worthley, Stephen G; Spriggs, Douglas; Tolleson, Thaddeus; Nazif, Tamim; Golwala, Harsh; Kander, Nathan H; Liew, Houng B; Sardella, Gennaro; Tamburino, Corrado; Lung, Te-Hsin; Mahoney, Cecile; Stone, Gregg W

Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear Results

接受为期 1 个月的双联抗血小板治疗的高出血风险糖尿病患者:Onyx ONE 清晰结果

Kedhi, Elvin; Windecker, Stephan; Latib, Azeem; Kirtane, Ajay J; Kandzari, David; Mehran, Roxana; Price, Matthew J; Abizaid, Alexandre; Simon, Daniel I; Zaman, Azfar; Fabbiocchini, Franco; Tie, Charlies; van 't Hof, Arnoud; de la Torre Hernandez, Jose M; Hammett, Christopher J; McLaurin, Brent; Potluri, Srinivasa; Smith, Timothy; Waksman, Ron; Ragosta, Michael; Parke, Maria; Lung, Te-Hsin; Stone, Gregg W

Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter

COVID-19 大流行对非 COVID-19 疫情中心 ST 段抬高型心肌梗死的影响

Hammad, Tarek A; Parikh, Melanie; Tashtish, Nour; Lowry, Cynthia M; Gorbey, Diane; Forouzandeh, Farshad; Filby, Steven J; Wolf, William M; Costa, Marco A; Simon, Daniel I; Shishehbor, Mehdi H

Door-to-balloon Time for ST-elevation MI in the Coronavirus Disease 2019 Era

2019冠状病毒病时代ST段抬高型心肌梗死患者的入院至球囊扩张时间

Mously, Haytham; Shah, Nischay; Zuzek, Zachary; Alshaghdali, Ibrahim; Karim, Adham; Jaswaney, Rahul; Filby, Steven J; Simon, Daniel I; Shishehbor, Mehdi H; Forouzandeh, Farshad

Implicating ILK in inflammation

ILK参与炎症反应

Plow, Edward F; Simon, Daniel I

Anisocytosis is Associated With Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults

细胞大小不均与 COVID-19 患者的短期死亡率相关,并且可能反映未感染门诊成年人的促炎特征

Hornick, Andrew; Tashtish, Nour; Osnard, Michael; Shah, Binita; Bradigan, Allison; Albar, Zainab; Tomalka, Jeffrey; Dalton, Jarrod; Sharma, Ashish; Sekaly, Rafick P; Hejal, Rana; Simon, Daniel I; Zidar, David A; Al-Kindi, Sadeer G

S100A9-targeted tobacco mosaic virus nanoparticles exhibit high specificity toward atherosclerotic lesions in ApoE(-/-) mice

靶向S100A9的烟草花叶病毒纳米颗粒对ApoE(-/-)小鼠的动脉粥样硬化病变表现出高度特异性。

Park, Jooneon; Gao, Huiyun; Wang, Yunmei; Hu, He; Simon, Daniel I; Steinmetz, Nicole F

The search for new antithrombotic mechanisms and therapies that may spare hemostasis

寻找可能不影响止血功能的新型抗血栓机制和疗法

Plow, Edward F; Wang, Yunmei; Simon, Daniel I